Testing effectiveness (Phase 2)Study completedNCT03373071
What this trial is testing
Anti-CD19 CAR T Cells in Pediatric Patients Affected by Relapsed/Refractory CD19+ ALL and NHL
Who this might be right for
CD19-ALLCD19-LNH
Bambino Gesù Hospital and Research Institute 29